Quick Answer
NovaBridge Biosciences reported Total Assets of $212.68 million for the year ending 2024.
- NovaBridge Biosciences showed a decrease of -42.4% in Total Assets from 2023 to 2024.
- This data is from NovaBridge Biosciences's annual report (Form 10-K), filed with the SEC on April 3, 2025.
- XBRL data for this metric is available from 2018 to 2024 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 7 years of available data (2018 to 2024), NovaBridge Biosciences's Total Assets has declined by 91.0%.
- Historical annual values: Fiscal year 2024: $212.68 million | Fiscal year 2023: $368.92 million | Fiscal year 2022: $4.07 billion | Fiscal year 2021: $5.60 billion | Fiscal year 2020: $6.33 billion | Fiscal year 2019: $1.74 billion | Fiscal year 2018: $2.38 billion.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: